PureForm is a biosciences company focused on the discovery and production of pure cannabinoids for use in treating disease and promoting wellness. PureForm uses its proprietary technology to produce rare cannabinoids that are safe, legal, and effective for wellness and pharmaceutical applications. Our synthetic platform can quickly and sustainably produce almost any molecule found in nature. Enabling superior supply chain economics while creating sustainable solutions for both natural and novel compounds. Our research and clean chemistry production platform enables a sustainable, safe, cost effective, commercial scale supply chain option for both pharmaceutical and consumer products companies to address widespread consumer adoption. PureForm uses Cyclic Terpene Assembly™ (CTA), it’s proprietary technology for assembling cannabinoids from naturally occurring terpenes. The Cannome™ is PureForm’s catalogue of cannabinoids - all pure molecules, synthesized using Natural Product Chemistry. PureForm CBD is PureForm’s first cannabinoid to go from bench to commercial scale cGMP production. PureForm’s proprietary platform is unlocking the potential of over 100 cannabinoids. Each cannabinoid is chirally pure and stereochemically identical to cannabinoids extracted from hemp and cannabis. PureForm has completed commercial scale-up of CBD and can produce metric ton quantities today. In addition to the production of cannabinoids found in hemp and cannabis, PureForm is also working on routes of synthesis to develop unique and novel compounds and cannabinoid-like derivatives targeting the endocannabinoid system that have the potential to be pharmaceutically relevant. Our Cyclic Terpene Assembly™ (CTA) technology delivers a high-performance alternative to agricultural and biosynthetic based production of molecules in a cost efficient and sustainable format.
